TRIALSPARK
TrialSpark is a technology-driven pharma company that runs end-to-end clinical trials, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial, enabling more efficient trial design, faster trial completion, and higher trial data quality. TrialSpark in-licenses and co-develops drug programs through in-house development, joint ventures, and NewCos.
TRIALSPARK
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2014-06-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.trialspark.com
Total Employee:
101+
Status:
Active
Total Funding:
156 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Wordpress Plugins
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Founder
Investors List
ArrowMark Partners
ArrowMark Partners investment in Series C - TrialSpark
John Doerr
John Doerr investment in Series C - TrialSpark
Felicis Ventures
Felicis Ventures investment in Series C - TrialSpark
Dragoneer Investment Group
Dragoneer Investment Group investment in Series C - TrialSpark
Casdin Capital
Casdin Capital investment in Series C - TrialSpark
Sam Altman
Sam Altman investment in Series C - TrialSpark
Spark Capital
Spark Capital investment in Series C - TrialSpark
Thrive Capital
Thrive Capital investment in Series C - TrialSpark
Lachy Groom
Lachy Groom investment in Series C - TrialSpark
Sequoia Capital
Sequoia Capital investment in Series C - TrialSpark
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-03-30 | January | TrialSpark investment in Series A - January | 10 M USD |
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2021-12-08 | TrialSpark hires two new executives to join the company's leadership team, Gavin Corcoran, MD (Chief Medical Officer) and James Leslie, MBA (Chief Financial Officer) |
Official Site Inspections
http://www.trialspark.com Semrush global rank: 2.97 M Semrush visits lastest month: 5.49 K
- Host name: ec2-54-146-249-230.compute-1.amazonaws.com
- IP address: 54.146.249.230
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149